American Century Companies Inc. Sells 499,312 Shares of Hill-Rom Holdings, Inc. (HRC)

American Century Companies Inc. cut its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 58.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 362,209 shares of the medical technology company’s stock after selling 499,312 shares during the period. American Century Companies Inc. owned approximately 0.55% of Hill-Rom worth $31,635,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of HRC. Vigilant Capital Management LLC bought a new stake in Hill-Rom in the second quarter worth $109,000. Three Peaks Capital Management LLC bought a new stake in Hill-Rom in the first quarter worth $111,000. Point72 Asia Hong Kong Ltd lifted its stake in Hill-Rom by 1,978.1% in the first quarter. Point72 Asia Hong Kong Ltd now owns 1,330 shares of the medical technology company’s stock worth $116,000 after purchasing an additional 1,266 shares during the last quarter. Campbell & CO Investment Adviser LLC bought a new stake in Hill-Rom in the first quarter worth $203,000. Finally, Hartford Investment Management Co. bought a new stake in Hill-Rom in the second quarter worth $215,000. 84.91% of the stock is owned by institutional investors and hedge funds.

In other news, SVP Alton Shader sold 16,812 shares of the company’s stock in a transaction dated Monday, June 11th. The shares were sold at an average price of $93.70, for a total transaction of $1,575,284.40. Following the completion of the transaction, the senior vice president now directly owns 54,898 shares of the company’s stock, valued at $5,143,942.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.90% of the company’s stock.

Shares of NYSE:HRC opened at $97.39 on Tuesday. The stock has a market cap of $6.52 billion, a PE ratio of 25.23, a PEG ratio of 1.52 and a beta of 0.94. The company has a quick ratio of 1.18, a current ratio of 1.58 and a debt-to-equity ratio of 1.24. Hill-Rom Holdings, Inc. has a 12 month low of $71.91 and a 12 month high of $98.96.

Hill-Rom (NYSE:HRC) last issued its quarterly earnings data on Friday, July 27th. The medical technology company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. The firm had revenue of $708.60 million during the quarter, compared to the consensus estimate of $707.50 million. Hill-Rom had a net margin of 8.19% and a return on equity of 20.54%. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.91 earnings per share. equities analysts anticipate that Hill-Rom Holdings, Inc. will post 4.64 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 28th. Stockholders of record on Friday, September 21st will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 0.82%. The ex-dividend date of this dividend is Thursday, September 20th. Hill-Rom’s dividend payout ratio (DPR) is 20.73%.

Several research firms have weighed in on HRC. Zacks Investment Research raised shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $98.00 price target for the company in a research note on Monday, July 2nd. Raymond James boosted their price target on shares of Hill-Rom from $97.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, July 30th. Needham & Company LLC reissued a “buy” rating and issued a $106.00 price target (up from $105.00) on shares of Hill-Rom in a research note on Monday, April 30th. Northcoast Research reissued a “buy” rating and issued a $104.00 price target on shares of Hill-Rom in a research note on Tuesday, July 31st. Finally, KeyCorp boosted their price target on shares of Hill-Rom from $97.00 to $115.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 17th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Hill-Rom presently has a consensus rating of “Buy” and an average target price of $100.00.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Further Reading: Market Capitalization in the Stock Market

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply